Categories: HealthcareNews

Fathom Taps Enoch Shih as Chief Operating Officer

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

New COO will have broad commercial responsibilities to support Fathom’s rapid growth.

SAN FRANCISCO–(BUSINESS WIRE)–Fathom, the leader in medical coding automation, announced that Enoch Shih has joined the company’s leadership team as Chief Operating Officer. Mr. Shih, who will report to Co-founder and CEO Andrew Lockhart, brings deep experience and expertise in scaling the operations of fast-growing technology companies like Fathom. In addition to broad commercial responsibilities, Mr. Shih will lead Fathom’s Customer Success, Implementations, Coding Quality, and People teams, while working closely with Fathom Co-founder and CTO Christopher Bockman.


“Enoch has built, grown, and led cross-functional organizations at scale and is a valuable addition to the Fathom team as we onboard dozens of new clients this year,” said Andrew Lockhart, co-founder and CEO of Fathom. ”His experience will accelerate Fathom’s growth as we scale our engineering, product, and commercial organizations.”

Mr. Shih joins as widespread labor shortages have forced health systems to adopt new technology at an unprecedented pace. In response to this demand, Fathom is rapidly growing its client base and expanding specialty coverage. Today, the company’s deep-learning technology offers 90%+ automation rates for emergency medicine, 97%+ for radiology, and 80%+ for other medical specialties. Since securing its Series B funding in November 2022, Fathom has partnered with dozens of new healthcare organizations seeking its industry-leading autonomous medical coding solution to improve coding quality and operating margins amid a challenging financial environment for providers.

“Fathom has built an exceptionally talented team and highly accurate, fast, cost-effective AI medical coding product for a market demanding innovation and efficiency,” said Fathom COO Enoch Shih. “Opportunities like this – combining purpose, people, impact, and growth – do not come up often, and I am beyond thrilled to partner with Andrew and Chris to accelerate our mission of understanding and structuring the world’s medical data.”

Before joining Fathom, Mr. Shih worked at Gusto for seven years, most recently as Chief Customer Officer. In this role, he led the customer success, onboarding, support, and operations teams to world-class net revenue retention and NPS while significantly scaling the team. Prior, he worked at the Boston Consulting Group and Deloitte Consulting, focusing on go-to-market, R&D, and operations for technology and healthcare companies.

Mr. Shih earned a Bachelor’s and Master’s of Accounting from The Ohio State University summa cum laude and an MBA from Stanford University’s Graduate School of Business, where he was an Arjay Miller Scholar.

For more information, visit fathomhealth.com and follow the company on LinkedIn.

Editors’ Note: A photo of Mr. Shih is available by contacting phyllis@clarityqst.com.

About Fathom

Fathom is the nation’s leading medical coding automation platform, an AI solution that fuses the best of deep learning and natural language processing (NLP) to automate medical coding with unprecedented accuracy and efficiency. Fathom provides the highest automation rates and the broadest specialty coverage to help clients increase speed and accuracy while reducing costs.

Fathom is backed by world-class investors, including 8VC, Alkeon Capital, ApolloMD, Cedars-Sinai, Founders Fund, GV, Lightspeed Venture Partners, Tarsadia, and Vituity’s Inflect Health. For more information, visit fathomhealth.com and follow the company on LinkedIn.

Contacts

Fathom Media Contacts:

Phyllis Grabot

phyllis@clarityqst.com
805.341.7269

Bonnie Quintanilla

bonnie@clarityqst.com
818.681.5777

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

1 day ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

1 day ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

1 day ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

1 day ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

1 day ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

1 day ago